Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
24-week randomized controlled trial of Leigongtengduogan Pian + Yishen Juanbi Wan versus methotrexate in rheumatoid arthritis
ChiCTR-TRC-10000989Phase 4Completed
- Sponsor
- The Ministry of Science and Technology of the People's Republic of China
- Start
- Aug 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tripterygium wilfordii polyglycosides, Yi Shen Juan Bi and methotrexate in rheumatoid arthritis (RA) (2 arms), sponsored by The Ministry of Science and Technology of the People's Republic of China. Primary endpoints: Rest pain, Joint tenderness and 8 more. Started Aug 2011; status: completed.
02
Drugs
tripterygium wilfordii polyglycosidesYi Shen Juan Bimethotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR-TRC-10000989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000989.